MARCOS
GONZÁLEZ DÍAZ
Investigador en el periodo 1993-2023
Hospital de la Santa Creu i Sant Pau
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital de la Santa Creu i Sant Pau (19)
2018
-
CXCR7 expression in diffuse large B-cell lymphoma identifies a subgroup of CXCR4+ patients with good prognosis
PLoS ONE, Vol. 13, Núm. 6
-
Focal adhesion genes refine the intermediate-risk cytogenetic classification of acute myeloid leukemia
Cancers, Vol. 10, Núm. 11
2017
-
NEDD 9 an independent good prognostic factor in intermediaterisk acute myeloid leukemia patients
Oncotarget, Vol. 8, Núm. 44, pp. 76003-76014
2016
-
A high proportion of cells carrying trisomy 12 is associated with a worse outcome in patients with chronic lymphocytic leukemia
Hematological Oncology, Vol. 34, Núm. 2, pp. 84-92
-
UGT2B17 minor histocompatibility mismatch and clinical outcome after HLA-identical sibling donor stem cell transplantation
Bone Marrow Transplantation, Vol. 51, Núm. 1, pp. 79-82
2015
-
CIP2A high expression is a poor prognostic factor in normal karyotype acute myeloid leukemia
Haematologica
-
CXCR4 expression enhances diffuse large B cell lymphoma dissemination and decreases patient survival
Journal of Pathology, Vol. 235, Núm. 3, pp. 445-455
-
Effect of mismatching for mHA UTA2-1 on clinical outcome after HLA-identical sibling donor allo-SCT
Bone Marrow Transplantation
-
The genotype of the donor for the (GT)n polymorphism in the promoter/enhancer of FOXP3 Is associated with the development of severe acute GVHD but does not affect the GVL effect after myeloablative HLA-Identical allogeneic stem cell transplantation
PLoS ONE, Vol. 10, Núm. 10
2010
-
Early intervention during imatinib therapy in patients with newly diagnosed chronic-phase chronic myeloid leukemia: A study of the Spanish PETHEMA group
Haematologica, Vol. 95, Núm. 8, pp. 1317-1324
2008
-
Fludarabine, cyclophosphamide, and mitoxantrone as initial therapy of chronic lymphocytic leukemia: High response rate and disease eradication
Clinical Cancer Research, Vol. 14, Núm. 1, pp. 155-161
2007
-
Antithrombin Cambridge II (A384S): An underestimated genetic risk factor for venous thrombosis
Blood, Vol. 109, Núm. 10, pp. 4258-4263
-
Outcome of patients with acute promyelocytic leukemia failing to front-line treatment with all-trans retinoic acid and anthracycline-based chemotherapy (PETHEMA protocols LPA96 and LPA99): Benefit of an early intervention
Leukemia, Vol. 21, Núm. 3, pp. 446-452
2005
-
Long-term outcome of allogeneic PBSC transplantation in pediatric patients with hematological malignancies: A report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON) and the Spanish Group for Allogeneic Peripheral Blood Transplantation (GETH)
Bone Marrow Transplantation, Vol. 36, Núm. 9, pp. 781-785
2004
-
Quantitative assessment of PML-RARa and BCR-ABL by two real-time PCR instruments: Multiinstitutional laboratory trial
Clinical Chemistry, Vol. 50, Núm. 6, pp. 1088-1092
-
Risk assessment and outcome of chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell transplantation in pediatric patients
Bone Marrow Transplantation, Vol. 34, Núm. 5, pp. 433-438
2003
-
Chimerism analysis following allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning
Bone Marrow Transplantation, Vol. 31, Núm. 5, pp. 387-392
2001
-
Disparity for the minor histocompatibility antigen HA-1 is associated with an increased risk of acute graft-versus-host disease (GvHD) but it does not affect chronic GvHD incidence, disease-free survival or overall survival after allogeneic human leucocyte antigen-identical sibling donor transplantation
British Journal of Haematology, Vol. 114, Núm. 4, pp. 931-936
1998
-
Peripheral T-cell lymphomas: Initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the R.E.A.L. Classification
Annals of Oncology, Vol. 9, Núm. 8, pp. 849-855